Skip to content
Friends of Cancer Research
FOCR 30 Year Anniversary
About
About
Friends
Team
Board of Directors
Financials & Policies
Scientific Reports
30th Anniversary
Projects
View All Projects
Research Partnerships
ai.RECIST Project
ctMoniTR Project
Digital PATH Project
ECA Pilot
Policy Initiatives
Cell & Gene Therapies
Clinical Trial Eligibility Criteria
Interim OS Project
Lung-MAP
Tolerability & Dosing
Analyses
Drug Development Dashboards
About Breakthrough Therapies
Search Breakthrough Therapies
Policy Portfolio
Events
Upcoming Events
Past Events
Annual Meeting
Cancer Leadership Awards
News
In The News
Blog: Engaging Innovation
Press Releases
Publications
View All Publications
Peer Reviewed Publications
Scientific Reports
White Papers
Posters
Advocacy
Friends
Advocacy Initiatives
Advisory Advocates
Advocacy Newsletter
Advocacy Education Programs
ProgressforPatients.org
Progreso para Pacientes
Donate
Search
Navigation Toggle
About
About
Friends
Team
Board of Directors
Financials & Policies
Scientific Reports
30th Anniversary
Projects
View All Projects
Research Partnerships
ai.RECIST Project
ctMoniTR Project
Digital PATH Project
ECA Pilot
Policy Initiatives
Cell & Gene Therapies
Clinical Trial Eligibility Criteria
Interim OS Project
Lung-MAP
Tolerability & Dosing
Analyses
Drug Development Dashboards
About Breakthrough Therapies
Search Breakthrough Therapies
Policy Portfolio
Events
Upcoming Events
Past Events
Annual Meeting
Cancer Leadership Awards
News
In The News
Blog: Engaging Innovation
Press Releases
Publications
View All Publications
Peer Reviewed Publications
Scientific Reports
White Papers
Posters
Advocacy
Friends
Advocacy Initiatives
Advisory Advocates
Advocacy Newsletter
Advocacy Education Programs
ProgressforPatients.org
Progreso para Pacientes
Donate
twitter
linkedin
youtube
Keyword search
Submit
Search
Close
Overall Survival
Overall Survival
Defined under
Clinical Trial Endpoints
.
More Cancer and Drug Development Terms
